11.05.2016

Välimäki VV et al. 2016; How well are the optimal serum 25OHD concentrations reached in high-dose intermittent vitamin D therapy? A placebo-controlled study on comparison between 100 000 IU and 200 000 IU of oral D3 every 3 months in elderly women; Clin. Endocrinol. 84(6):837-44

…only with marginal difference. Approximately half of all measurements of 25OHD in both groups reached the goal of 75 nmol/l. Conclusions: Both applied dosis regimens are not able to keep…

10.02.2015

Laborchemie Apolda

…laboratory to production. As a result of the close collaboration with various university research institutes and research-intensive high-tech companies, all developments are based on the latest state of science and

13.02.2015

Rheumatoid Arthritis

…physical examination can give clues as to how far along the disease is. Blood tests carried out in laboratories to determine relevant parameters for this disease provide further assistance in…

13.02.2015

Toxoplasmosis

Toxoplasmosis is a parasitic disease caused by toxoplasma gondii. The main host of these parasites is the cat; in other stages of its development, the toxoplasma gondii uses the human…

29.04.2016

Metalcaptase® 150 mg

…able to form complexes with heavy metals, particularly copper, which are eliminated through the kidneys. Due to this complex forming ability, Metalcaptase® is the drug of choice for medicinal therapy…

14.06.2016

Metalcaptase® 300 mg

…eliminated through the urine. The kidney is not able to reabsorb the cystine and other amino acids into the body from the primary urine (tubular reabsorption disturbance). The cystine, which…